Terms: = Sarcomas AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Treatment
17402 results:
1. Glycolic acid and D-lactate-putative products of DJ-1-restore neurodegeneration in FUS - and SOD1-ALS.
Pal A; Grossmann D; Glaß H; Zimyanin V; Günther R; Catinozzi M; Boeckers TM; Sterneckert J; Storkebaum E; Petri S; Wegner F; Grill SW; Pan-Montojo F; Hermann A
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760174
[TBL] [Abstract] [Full Text] [Related]
2. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on sarcomas (GEIS) study.
Moura DS; Mondaza-Hernandez JL; Sanchez-Bustos P; Peña-Chilet M; Cordero-Varela JA; Lopez-Alvarez M; Carrillo-Garcia J; Martin-Ruiz M; Romero-Gonzalez P; Renshaw-Calderon M; Ramos R; Marcilla D; Alvarez-Alegret R; Agra-Pujol C; Izquierdo F; Ortega-Medina L; Martin-Davila F; Hernandez-Leon CN; Romagosa C; Salgado MAV; Lavernia J; Bagué S; Mayodormo-Aranda E; Alvarez R; Valverde C; Martinez-Trufero J; Castilla-Ramirez C; Gutierrez A; Dopazo J; Hindi N; Garcia-Foncillas J; Martin-Broto J
Cell Mol Life Sci; 2024 May; 81(1):219. PubMed ID: 38758230
[TBL] [Abstract] [Full Text] [Related]
3. Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
Nasri E; Torrence DE; Vasilopoulos T; Knapik JA; Lagmay JP; Reith JD; Gibbs CP
Cancer J; 2024 May-Jun 01; 30(3):133-139. PubMed ID: 38753746
[TBL] [Abstract] [Full Text] [Related]
4. Prospective phase II trial of preoperative hypofractionated proton therapy for extremity and truncal soft tissue sarcoma: the PRONTO study rationale and design.
Gogineni E; Chen H; Hu C; Boudadi K; Engle J; Levine A; Deville C
Radiat Oncol; 2024 May; 19(1):56. PubMed ID: 38745333
[TBL] [Abstract] [Full Text] [Related]
5. Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.
Sobczyk P; Sobstyl M; Acewicz A; Rosa J; Grabiec M; Grajkowska W
Folia Neuropathol; 2024; 62(1):96-101. PubMed ID: 38741436
[TBL] [Abstract] [Full Text] [Related]
6. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
[TBL] [Abstract] [Full Text] [Related]
7. Osteosarcoma After Total Knee Arthroplasty: A Case Report.
Martínez-Collado P; Pujol O; Bustos A; Plomer M; Carrasco MG; Silva T; Vélez R; Minguell J
JBJS Case Connect; 2024 Apr; 14(2):. PubMed ID: 38728527
[TBL] [Abstract] [Full Text] [Related]
8. Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Kho S; Seung KJ; Huerga H; Bastard M; Khan PY; Mitnick CD; Rich ML; Islam S; Zhizhilashvili D; Yeghiazaryan L; Nikolenko EN; Zarli K; Adnan S; Salahuddin N; Ahmed S; Vargas ZHR; Bekele A; Shaimerdenova A; Tamirat M; Gelin A; Vilbrun SC; Hewison C; Khan U; Franke M
Nat Commun; 2024 May; 15(1):3927. PubMed ID: 38724531
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.
Turjap M; Pelcová M; Gregorová J; Šmak P; Martin H; Štingl J; Peš O; Juřica J
Ther Drug Monit; 2024 Jun; 46(3):321-331. PubMed ID: 38723115
[TBL] [Abstract] [Full Text] [Related]
10. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
[TBL] [Abstract] [Full Text] [Related]
11. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
[TBL] [Abstract] [Full Text] [Related]
12. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
13. [Analysis of the effect of different facial nerve managements applied to tumor resection in the jugular foramen region].
Yin Y; Zhao Y; Tian X; Zhao Y; Chen H; Zhang L; Gao Z; Feng G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):368-371;375. PubMed ID: 38686470
[No Abstract] [Full Text] [Related]
14. Targeting KRAS in pancreatic cancer.
Stickler S; Rath B; Hamilton G
Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
Shalaby N; Zaki HF; Badary OA; Kamal S; Nagy M; Makhlouf D; Elnashar A; Elnadi E; Abdelshafi SA; Abouelnaga S; Saber MM
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1391-1409. PubMed ID: 38680001
[TBL] [Abstract] [Full Text] [Related]
16. Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis.
Imai T; Kojima Y; Shimoi T; Aiba H; Okuma HS; Saito A; Kita S; Yamamoto K; Maejima A; Nishikawa T; Sudo K; Noguchi E; Yoshida A; Matsui Y; Iwata S; Kobayashi E; Kawai A; Udagawa R; Fujiwara Y; Yonemori K
Anticancer Res; 2024 May; 44(5):2125-2132. PubMed ID: 38677749
[TBL] [Abstract] [Full Text] [Related]
17. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
18. Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors.
Xie M; Gong T; Wang Y; Li Z; Lu M; Luo Y; Min L; Tu C; Zhang X; Zeng Q; Zhou Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673726
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue sarcomas of the Extremities in a Colombian Reference Cancer Center.
Díaz Casas SE; Villacrés JM; Lehmann Mosquera C; García Mora M; Mariño Lozano I; Ángel Aristizábal J; Suarez Rodríguez R; Duarte Torres CA; Sánchez Pedraza R
Curr Oncol; 2024 Mar; 31(4):1725-1738. PubMed ID: 38668034
[No Abstract] [Full Text] [Related]
20. Protecting Orthopaedic Implants from Infection: Antimicrobial Peptide Mel4 Is Non-Toxic to Bone Cells and Reduces Bacterial Colonisation When Bound to Plasma Ion-Implanted 3D-Printed PAEK Polymers.
Kruse HV; Chakraborty S; Chen R; Kumar N; Yasir M; Lewin WT; Suchowerska N; Willcox MDP; McKenzie DR
Cells; 2024 Apr; 13(8):. PubMed ID: 38667271
[TBL] [Abstract] [Full Text] [Related]
[Next]
